Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
561. |
ECCT/26/06/02 | HibiscusJr A global phase 3 Randomised, Double-blind and Placebo-controlled Study Evaluating the Efficacy and Safety of etavopivat in children with Sickle Cell Disease. |
Principal Investigator(s) 1. Dr. Sharon Mokeira Ocharo Site(s) in Kenya 1. Victoria Biomedical Research Institute (Kisumu county) |
23-10-2026 |
View |
562. |
ECCT/11/04/01 | A Double-blind, Randomized Trial of Monthly Treatment with Metronidazole and Miconazole Co-formulated Suppositories versus Placebo for Preventing Vaginal Infections in HIVSeronegative Women (DMID Protocol Number: 09-0070) |
Principal Investigator(s) 1. Raymond Scott McClelland Site(s) in Kenya 1. Kenya AIDS Vaccine Initiative (Nairobi City county) 2. Kenya AIDS Control Program (Nairobi City county) 3. Mombasa HIV/STD Research Clinic (Mombasa county) |
23-06-2011 |
View |
563. |
ECCT/21/07/02 | TALIOS A 3-ARM, RANDOMIZED, BLINDED, ACTIVE-CONTROLLED, PHASE II STUDY OF RO7121661, A PD1-TIM3 BISPECIFIC ANTIBODY AND RO7247669, A PD1-LAG3 BISPECIFIC ANTIBODY, COMPARED WITH NIVOLUMAB IN PARTICIPANTS WITH ADVANCED OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS |
Principal Investigator(s) 1. Fredrick Chite Asirwa Site(s) in Kenya 1. Aga Khan University, Nairobi (Nairobi City county) 2. International Cancer Institute (Uasin Gishu county) |
01-11-2021 |
View |
564. |
ECCT/16/10/02 | PAINT Study A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral-naïve HIV-1 infected adolescents and children aged ≥6 to <18 years |
Principal Investigator(s) 1. Professor Walter Jaoko Site(s) in Kenya 1. KAVI Institute of Clinical Research (Nairobi City county) 2. Kenya Medical Research Institute/Walter Reed Project, HIV Program (Kericho county) |
13-02-2017 |
View |
565. |
ECCT/22/09/03 | SINGLE DOSE VERSUS EXTENDED DO EFFECTIVENESS OFSINGLE-DOSE ANTIBIOTIC USE IN ELECTIVE CAESAREANSECTION IN PREVENTION OF SURGICAL SITE INFECTION AT JARAMOGI OGINGA ODINGA TEACHING AND REFERRAL HOSPITAL, KISUMU COUNTY,KENYA: A RANDOMIZED CONTROL TRIAL. |
Principal Investigator(s) 1. STEVEN ODHIAMBO JUMA Site(s) in Kenya JARAMOGI OGINGA ODINGA TEACHING AND REFERRAL HOSPITAL |
26-09-2022 |
View |
566. |
ECCT/23/02/03 | INTREPiD Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy with High-Sensitivity Diagnostics (INTREPiD). |
Principal Investigator(s) 1. Steve M Taylor 2. Jeremiah K Laktabai Site(s) in Kenya Bungoma County |
23-07-2023 |
View |
567. |
ECCT/24/04/05 | Phase III Vitiligo Study A Double-Arm, Open Label, Phase III Study to Compare the Efficacy and Safety of SCENESSE® and Narrow-Band Ultraviolet B (NB-UVB) Light versus NB- UVB Light Alone in the Treatment of Vitiligo |
Principal Investigator(s) 1. Dr. Hannah Wanyika Wanyika Site(s) in Kenya Kenyatta National Hospital - |
30-08-2024 |
View |
568. |
ECCT/22/01/01 | ASTEFANIA A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ADJUVANT ATEZOLIZUMAB OR PLACEBO AND TRASTUZUMAB EMTANSINE FOR HER2-POSITIVE BREAST CANCER AT HIGH RISK OF RECURRENCE FOLLOWING PREOPERATIVE THERAPY |
Principal Investigator(s) 1. Mansoor Saleh 2. Fredrick Chite Asirwa Site(s) in Kenya 1. Aga Khan University, Nairobi (Nairobi City county) 2. International Cancer Institute (Uasin Gishu county) |
21-07-2022 |
View |
569. |
ECCT/26/02/01 | E-MASTER STUDY: PHASE 1 Diagnosis of postpartum haemorrhage at caesarean section: a multi-country diagnostic and prognostic accuracy study (E-MASTER: PHASE 1) |
Principal Investigator(s) 1. Zahida Qureshi 2. Alfred Osoti 3. George Gwako Site(s) in Kenya 1. Mbagathi County Referral Hospital (Nairobi City county) |
19-06-2026 |
View |
570. |
ECCT/19/06/03 | Evaluation of the RTS,S vaccine implementation in Kenya (MVPE) An evaluation of the cluster-randomised pilot implementation of the RTS,S/AS01 malaria vaccine through routine health systems in western Kenya |
Principal Investigator(s) 1. Aaron Samuels Samuels Site(s) in Kenya 1. Bungoma County (Bung\'oma county) 2. Busia County (Busia county) 3. Homa Bay (Homa Bay county) 4. Kakamega County (Kakamega county) 5. Kisumu County (Kisumu county) 6. Migori County (Migori county) 7. Siaya County (Siaya county) 8. Vihiga County (Vihiga county) |
13-08-2019 |
View |